Oral epithelial dysplasia: Classifications and clinical relevance in risk assessment of oral potentially malignant disorders
- PMID: 31110412
- PMCID: PMC6503768
- DOI: 10.4103/jomfp.JOMFP_13_19
Oral epithelial dysplasia: Classifications and clinical relevance in risk assessment of oral potentially malignant disorders
Abstract
After more than a decade, the World Health Organization (WHO) published the revised grading system for oral epithelial dysplasia in 2017. The revised classification has changes reflecting our evolution of understanding of the dysplastic process. Although the WHO 2017 three-tier grading system is the gold standard for histological diagnosis of oral potentially malignant disorders, it has certain limitations. Suggestions to overcome these limitations include the use of clinical determinants and molecular markers to supplement the grading system. It has also been suggested that a two-tier system may be more reproducible and clinically translatable for better management. These advances in the understanding of epithelial dysplasia are very important globally and for us in the Indian subcontinent, given the prevalence of habits (tobacco/areca nut) and burden of oral cancer in this part of the world. The following review traces the evolution of the grading system of dysplasia, its relevance and clinical utility.
Keywords: Cancer; epithelial; grading; histopathology; oral dysplasia; potentially malignant; precancer.
Conflict of interest statement
There are no conflicts of interest.
Similar articles
-
Current challenges and the diagnostic pitfalls in the grading of epithelial dysplasia in oral potentially malignant disorders: A review.J Oral Biol Craniofac Res. 2020 Oct-Dec;10(4):788-799. doi: 10.1016/j.jobcr.2020.09.005. Epub 2020 Sep 19. J Oral Biol Craniofac Res. 2020. PMID: 33194541 Free PMC article.
-
Potential Immunohistochemical Biomarkers for Grading Oral Dysplasia: A Literature Review.Biomedicines. 2024 Mar 5;12(3):577. doi: 10.3390/biomedicines12030577. Biomedicines. 2024. PMID: 38540190 Free PMC article. Review.
-
Evaluation of a new binary system of grading oral epithelial dysplasia for prediction of malignant transformation.Oral Oncol. 2006 Nov;42(10):987-93. doi: 10.1016/j.oraloncology.2005.12.014. Epub 2006 May 30. Oral Oncol. 2006. PMID: 16731030
-
Oral Potentially Malignant Disorders (OPMD): What is the clinical utility of dysplasia grade?Expert Rev Mol Diagn. 2021 Mar;21(3):289-298. doi: 10.1080/14737159.2021.1898949. Epub 2021 Mar 16. Expert Rev Mol Diagn. 2021. PMID: 33682567 Review.
-
Ki67, CD105, and α-SMA expressions better relate the binary oral epithelial dysplasia grading system of World Health Organization.J Oral Pathol Med. 2017 Nov;46(10):921-927. doi: 10.1111/jop.12612. Epub 2017 Jul 25. J Oral Pathol Med. 2017. PMID: 28672080
Cited by
-
Small Dysplastic Oral Leucoplakia in a Smoking Woman: a Case Report.J Oral Maxillofac Res. 2021 Mar 31;12(1):e5. doi: 10.5037/jomr.2021.12105. eCollection 2021 Jan-Mar. J Oral Maxillofac Res. 2021. PMID: 33959240 Free PMC article.
-
Specific Oral Microbial Differences in Proteobacteria and Bacteroidetes Are Associated with Distinct Sites When Moving from Healthy Mucosa to Oral Dysplasia-A Microbiome and Gene Profiling Study and Focused Review.Microorganisms. 2023 Sep 7;11(9):2250. doi: 10.3390/microorganisms11092250. Microorganisms. 2023. PMID: 37764094 Free PMC article.
-
Current challenges and the diagnostic pitfalls in the grading of epithelial dysplasia in oral potentially malignant disorders: A review.J Oral Biol Craniofac Res. 2020 Oct-Dec;10(4):788-799. doi: 10.1016/j.jobcr.2020.09.005. Epub 2020 Sep 19. J Oral Biol Craniofac Res. 2020. PMID: 33194541 Free PMC article.
-
Evaluation of CYP1B1, oxidative stress and phase II detoxification enzyme status in oral cancer progression model.J Oral Biol Craniofac Res. 2024 Mar-Apr;14(2):169-174. doi: 10.1016/j.jobcr.2024.02.001. Epub 2024 Feb 15. J Oral Biol Craniofac Res. 2024. PMID: 38384675 Free PMC article.
-
Oral Epithelial Dysplasia in Tobacco Non-habitués: A Case Report and Review of Literature.Cureus. 2023 Oct 20;15(10):e47362. doi: 10.7759/cureus.47362. eCollection 2023 Oct. Cureus. 2023. PMID: 38022123 Free PMC article.
References
-
- Sankaranarayanan R, Ramadas K, Amarasinghe H, Subramanian S, Johnson N. Oral cancer: Prevention, early detection, and treatment. In: Gelband H, Jha P, Sankaranarayanan R, Horton S, editors. Cancer: Disease Control Priorities. 3rd ed. Ch. 5. Vol. 3. Washington, (DC): The International Bank for Reconstruction and Development/The World Bank; 2015. - PubMed
-
- Kalavrezos N, Scully C. Mouth cancer for clinicians. Part 2: Epidemiology. Dent Update. 2015;42:354–6. 358-9. - PubMed
-
- Sankaranarayanan R, Ramadas K, Thomas G, Muwonge R, Thara S, Mathew B, et al. Effect of screening on oral cancer mortality in Kerala, India: A cluster-randomised controlled trial. Lancet. 2005;365:1927–33. - PubMed
-
- Reibel J. Prognosis of oral pre-malignant lesions: Significance of clinical, histopathological, and molecular biological characteristics. Crit Rev Oral Biol Med. 2003;14:47–62. - PubMed
-
- van der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol. 2009;45:317–23. - PubMed